Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay
Table 1
Characteristics of study population.
SLE patients (70)
Healthy subjects (50)
value
Gender (female/male)
64/6
35/15
0.0032
Age (years, median (IQR))
46.5 (38.0-57.8)
44 (34.8-50.0)
0.1174
Serology
EBV-seropositive
68
46
EBV-seronegative
2
4
0.2331
HCMV-seropositive
56
35
HCMV-seronegative
14
15
0.2795
DNAemia
EBV DNA-positive
30
4
<0.0001
HCMV DNA-positive
3
0
0.2821
Viral load
EBV DNA (copies/ml, median (IQR))
233 (100-656.3)
125 (62.5-225)
0.1895
HCMV DNA (copies/ml, median (IQR))
200 (100-1000)
Undetectable
Immunosuppression
lp-IS
25
mhp-IS
45
SLEDAI score
<4
45
≥4
25
Demographic characteristics of SLE population and healthy controls are summarized in the table. () values were calculated using Fisher’s exact test.